期刊
JOURNAL OF INVESTIGATIVE DERMATOLOGY
卷 139, 期 6, 页码 1294-1305出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jid.2018.11.018
关键词
-
类别
资金
- German Federal Ministry of Education and Research [01ZX1312A]
- Bayer AG
- Sanofi-Aventis Deutschland GmbH
Hidradenitis suppurativa (HS) (also designated acne inversa) is a chronic inflammatory disease characterized by painful purulent skin lesions and progressive destruction of skin architecture. Despite the high burden for the patients, pathogenetic pathways underlying HS alterations remain obscure. When we examined the HS cytokine pattern, IL-1 beta turned out to be a highly prominent cytokine, overexpressed even compared with psoriatic lesions. Analyses of IL-1 beta-induced transcriptome in various cell types showed overlapping profiles, with upregulations of molecules causing immune cell infiltration and extracellular matrix degradation, and of specific cytokines including IL-6, IL-32, and IL-36. Matching cellular IL-1 receptor levels, dermal fibroblasts showed both the strongest and broadest IL-1 beta response, which was not clearly shared or strengthened by other cytokines. The IL-1 beta signature was specifically present in HS lesions and could be reversed by application of IL-1 receptor antagonist. Search for blood parameters associated with IL-1 beta pathway activity in HS identified serum amyloid A, which was synergistically induced by IL-1 beta and IL-6 in hepatocytes. Consequently, strongly elevated blood serum amyloid A levels in HS correlated positively with the extent of inflammatory skin alterations. In summary, the IL-1 beta pathway represents a pathogenetic cascade, whose activity may be therapeutically targeted and monitored by blood SAA levels.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据